<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05616026</url>
  </required_header>
  <id_info>
    <org_study_id>#11-21-ICTSHD-16</org_study_id>
    <nct_id>NCT05616026</nct_id>
  </id_info>
  <brief_title>Texts for Diabetes Control Among Homeless Persons</brief_title>
  <official_title>Short-messaging Services (SMS) Text for Uncontrolled Diabetes Among Persons Experiencing Homelessness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>George Washington University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods&#xD;
      to assess the impact of a SMS text strategy in diabetes control among persons who experience&#xD;
      homelessness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes mellitus (DM) is common among persons experiencing homelessness (PEH), often&#xD;
      inadequately managed, and carries significant costs. SMS strategies for DM have not been&#xD;
      tested among PEH despite the accessibility of mobile phones. This study uses a SMS strategy&#xD;
      to offer better communication, education, and information management; improve outreach;&#xD;
      facilitate care coordination; explore barriers to care; and support behavior changes. This&#xD;
      mixed-methods (RCT and qualitative) study will be implemented in shelter-clinics in New York&#xD;
      City in collaboration with community organizations, allowing for sustainability and&#xD;
      scalability. Aim 1 will evaluate the efficacy of a 6-month SMS program for DM management&#xD;
      versus an attention control on changes in HbA1c and adherence to DM self-care activities,&#xD;
      medications, and appointments at 9 months in adult PEH with uncontrolled DM (n=100). Outcomes&#xD;
      will be measured at 0, 3, 6, &amp;9 months. Aim 2 will assess patients' and providers' attitudes,&#xD;
      acceptability, and experience of the program through semi-structured interviews with PEH and&#xD;
      providers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2023</start_date>
  <completion_date type="Anticipated">November 15, 2024</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Intervention versus Control group; Randomized at the Individual level</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>9 months</time_frame>
    <description>Hemoglobin A1c level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Summary of Diabetes Self-Care Activities (SDSCA)</measure>
    <time_frame>9 months</time_frame>
    <description>Summary of Diabetes Self-Care Activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Days Covered (PDC)</measure>
    <time_frame>9 months</time_frame>
    <description>Medication Adherence through Proportion of Days Covered of Medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appointment Adherence</measure>
    <time_frame>9 months</time_frame>
    <description>Proportion of appointment adherence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention (INT) will include 6 months of DM management support via SMS texts including reminders for medication adherence, appointments, and DM self-care activities as well as education, and support.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control (CL) will receive 6 months of texts for general health promotion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intervention</intervention_name>
    <description>6 months of diabetes management support via SMS texts including reminders for medication adherence, appointments, and diabetes self-care activities as well as education, and support</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Diabetes SMS text</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention Control</intervention_name>
    <description>6 months of texts for general health promotion</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Homeless person age ≥ 21&#xD;
&#xD;
          -  Diagnosed with type 2 DM&#xD;
&#xD;
          -  Most recent visit HbA1c ≥ 8%&#xD;
&#xD;
          -  English/Spanish speaking&#xD;
&#xD;
          -  Connected to study sites' shelter-clinics for care&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or within 3 months postpartum&#xD;
&#xD;
          -  Has an uncontrolled severe illness&#xD;
&#xD;
          -  Has had a heart attack or stroke in the previous 6 months&#xD;
&#xD;
          -  Inability to read/respond to texts&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
&#xD;
          -  Receiving inpatient care for severe substance abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ramin Asgary, MD, MPH</last_name>
    <phone>917-684-9331</phone>
    <email>raminasgary1@gwu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leah Bauder, MPH</last_name>
    <phone>970-682-0940</phone>
    <email>leahbaud@gwu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramin Asgary, MD</last_name>
      <phone>202-994-6803</phone>
      <email>raminasgary1@gwu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Leah Bauder, MPH</last_name>
      <email>leahbaud@gwu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>November 4, 2022</study_first_submitted>
  <study_first_submitted_qc>November 10, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>February 14, 2023</last_update_submitted>
  <last_update_submitted_qc>February 14, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Washington University</investigator_affiliation>
    <investigator_full_name>Ramin Asgary</investigator_full_name>
    <investigator_title>Associate Professor School oh Public Health, PI</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Homelessness</keyword>
  <keyword>SMS text</keyword>
  <keyword>mobile Health</keyword>
  <keyword>Clinical trial</keyword>
  <keyword>Health disparities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

